α-Cyclodextrin/oil beads as a new carrier for improving the oral bioavailability of lipophilic drugs

Journal of Controlled Release

Volumn 122, Issue 1, 2007, Pages 47-53

  Trichard, Laury ^a   Fattal, Elias ^a   Besnard, Madeleine ^a   Bochot, Amélie ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Bead; Cyclodextrin; Isotretinoin; Lipid carrier; Oral bioavailability; Vegetable oil

Indexed keywords

ENCAPSULATION; LIPIDS; VEGETABLE OILS;

ISOTRETINOIN; LIPID CARRIER; ORAL BIOAVAILABILITY;

CYCLODEXTRINS;

ALPHA CYCLODEXTRIN; DRUG CARRIER; ISOTRETINOIN; SOYBEAN OIL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ALPHA-CYCLODEXTRINS; ANIMALS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG STABILITY; ISOTRETINOIN; KINETICS; MALE; PARTICLE SIZE; PLANT OILS; RATS; RATS, SPRAGUE-DAWLEY; SOLUTIONS; SOYBEAN OIL;

EID: 34548014986     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.06.004     Document Type: Article

References (23)

1. Woodley J.F. Liposomes for oral administration of drugs. Crit. Rev. Ther. Drug Carr. Syst. 2 1 (1985) 1-18
2. Mayer C. Nanocapsules as drug delivery systems. Int. J. Artif. Organs 28 11 (2005) 1163-1171
3. Gursoy R.N., and Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58 3 (2004) 173-182
4. Bummer P.M. Physical chemical considerations of lipid-based oral drug delivery-solid lipid nanoparticles. Crit. Rev. Ther. Drug Carr. Syst. 21 1 (2004) 1-20
5. Uner M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie 61 5 (2006) 375-386
6. Bochot A., Trichard L., Le Bas G., Alphandary H., Grossiord J.-L., Duchêne D., and Fattal E. α-cyclodextrin/oil beads: an innovative self-assembling system. Int. J. Pharm. 339 1-2 (2007) 121-129
7. Irie T., and Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86 2 (1997) 147-162
8. Okuno M., Kojima S., Matsushima-Nishiwaki R., Tsurumi H., Muto Y., Friedman S.L., and Moriwaki H. Retinoids in cancer chemoprevention. Curr. Cancer Drug Targets 4 3 (2004) 285-298
9. Buletic Z., Soprano K.J., and Soprano D.R. Retinoid targets for the treatment of cancer. Crit. Rev. Eukaryot. Gene Expr. 16 3 (2006) 193-210
10. Tan X., Meltzer N., and Lindenbaum S. Solid state stability studies of 13-cis-retinoic acid and all-trans-retinoic acid using microcalorimetry and HPLC analysis. Pharm. Res. 9 9 (1992) 1203-1208
11. Tan X., Meltzer N., and Lindenbaum S. Determination of the kinetics of degradation of 13-cis-retinoic acid and all-trans-retinoic acid in solution. J. Pharm. Biomed. Anal. 11 9 (1993) 817-822
12. Motto M.G., Facchine K.L., Hamburg P.F., Burinsky D.J., Dunphy R., Oyler A.R., and Cotter M.L. Separation and identification of retinoic acid photoisomers. J. Chromatogr. A 481 (1989) 255-262
13. Wang C.J., Pao L.H., Hsiong C.H., Wu C.Y., Whang-Peng J.J., and Hu O.Y. Novel inhibition of cis/trans retinoic acid interconversion in biological fluids - an accurate method for determination of trans and 13-cis retinoic acid in biological fluids. J. Chromatogr. B, Biomed. Sci. Appl. 796 2 (2003) 283-291
14. Ioele G., Cione E., Risoli A., Genchi G., and Ragno G. Accelerated photostability study of tretinoin and isotretinoin in liposome formulations. Int. J. Pharm. 293 1-2 (2005) 251-260
15. Liu J., Hu W., Chen H., Ni Q., Xu H., and Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 382 2 (2007) 191-195
16. Munoz Botella S., Lerner D.A., del Castello B., and Martin M.A. Analytical applications of retinoid-cyclodextrin inclusion complexes. Part 2. Luminescent properties at room temperature. Analyst 121 11 (1996) 1557-1560
17. Yap K.L., Liu X., Thenmozhiyal J.C., and Ho P.C. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis. Eur. J. Pharm. Sci. 25 1 (2005) 49-56
18. Loftsson T., Jarho P., Masson M., and Jarvinen T. Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2 2 (2005) 335-351
19. Bempong D.K., Honigberg I.L., and Metlzer N.M. Normal phase LC-MS determination of retinoic acid degradation products. J. Pharm. Biomed. Anal. 13 3 (1995) 285-291
20. Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit. Rev. Ther. Drug Carr. Syst. 16 5 (1999) 461-521
21. Leroy-Lechat F., Wouessidjewe D., Andreux J.P., Puisieux F., and Duchêne D. Evaluation of the cytotoxicity of cyclodextrins and hydroxypropylated derivates. Int. J. Pharm. 101 1-2 (1994) 97-103
22. Rajewski R.A., and Stella V.J. Pharmaceutical applications of cyclodextrins.2. In vivo drug delivery. J. Pharm. Sci. 85 11 (1996) 1142-1169
23. Shimada K., Kawano K., Ihsii J., and Nakamura T. Structure of inclusion complexes of cyclodextrins with triglyceride at vegetable oil/water interface. J. Food Sci. 57 (1992) 655-656